Defying convention.

As leaders in the life sciences, our Directors share our vision for the potential of Synthetic Biotic medicines and challenge us daily to achieve more to advance our mission. Having served at the helm of biotechnology companies and investment firms, our Directors serve as strategic partners and advisors guiding us to achieve progress for patients and the field.

Peter Barrett, PhD

Chairman, Partner, Atlas Venture

Aoife M. Brennan, MB, ChB

President, Chief Executive Officer, Chief Medical Officer

Chau Q. Khuong

Partner, Orbimed Advisors

Nick Leschly

CEO, bluebird bio

Ed Mathers

Partner, New Enterprise Associates

Michael Powell, PhD

General Partner, Sofinnova Ventures

Richard P. Shea

CFO, Syndax Pharmaceuticals

Patricia N. Hurter, PHD

Incoming CEO, Lyndra Therapeutics